The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Ezechi, Oliver Chukwujekwu ^a,b   Ostergren, Per Olof ^b   Nwaokorie, Francisca Obiageri ^a   Ujah, Innocent Achaya Otobo ^a   Odberg Pettersson, Karen ^b  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Antiretroviral therapy; Cervical cancer; HIV; Human papilloma virus (HPV)

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; NIGERIA; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SOCIAL ASPECT; UTERINE CERVIX CANCER; VERRUCA VULGARIS; WART VIRUS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REPRODUCTIVE TRACT INFECTIONS; RISK FACTORS; YOUNG ADULT;

EID: 84892682351     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-5     Document Type: Article

References (46)

1. Cervical cancer: the sub-Saharan African perspective. Anorlu RI, Reprod Health Matters 2008 16 32 41 49 10.1016/S0968-8080(08)32415-X 19027621
2. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA, J Med Virol 2007 79 6 758 765 10.1002/jmv.20817 17457908
3. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Luquea AE, Hittib J, Mwacharic C, Lanea C, Messing S, Cohna SE, et al. Int J Infect Dis 2010 14 9 810 e814 doi:10.1016/j.ijid.2010.03.016 10.1016/j.ijid.2010.03.016 20655263
4. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. J Natl Cancer Inst 2005 97 577 586 10.1093/jnci/dji073 15840880
5. Effect of viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV infected men. Jong E, van Gorp ECM, Mulder JW, Tol A, Smits PHM, Int J STD AIDS 2009 20 262 264 10.1258/ijsa.2008.008359 19304972
6. The distribution of sexually transmitted Human Pappillomaviruses in HIV positive and negative patients in Zambia. Ngandwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC, Africa BMC Infect Dis 2007 7 77 doi:10.1186/1471-2334- 7-77 10.1186/1471-2334-7-77
7. Federal Ministry of Health, Nigeria (FMoH), National guidelines for HIV and AIDs treatment and care in adolescents and adults Abuja Nigeria: FMoH 2010
8. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Louie KS, de Sanjose S, Mayaud P, Trop Med int Health 2009 14 10 1287 1302 10.1111/j.1365-3156.2009.02372.x 19772550
9. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S, Br J Cancer 2003 88 1 63 73 10.1038/sj.bjc.6600688 12556961
10. Human papillomavirus types among women infected with HIV: a meta-analysis. Clifford GM, Goncalves MAG, Franceschi S, AIDS 2006 20 2337 2344 10.1097/01.aids.0000253361.63578.14 17117020
11. Beth C, Eisen G, Meloni S, Idoko J, Onwujekwe D, Olaleye D, Gashau W, et al. Nigerian HIV-1 substypes and resistance to first line antiretroviral therapy Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV/AIDS 2010
12. Phyllis K, Chaplin B, Eisen G, Meloni S, Idoko J, Onwujekwe D, et al. Impact of HIV type 1 protease polymorphisms in a Nigerian population Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV/AIDS 2010
13. Adu RA, Ezechi OC, Onwujekwe DI, Odunukwe NN, David AN, Kalejaiye OO, et al. The changing pattern of HIV related deaths in south western Nigeria Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV/AIDS 2010
14. Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003. Campos DP, Riberio SR, Grinsztejn B, Veloso VG, Valente JG, Bastos FI, et al. AIDS 2005 19 Suppl 4 22 S26 10.1097/01.aids.0000191486.92285. 1c 16249649
15. Cervical dysplasia in Nigerian women Infected with HIV. Agaba PA, Thacher TD, Ekwempu CC, Idoko JA, Int J Gynecol Obstet 2009 107 99 102 10.1016/j.ijgo.2009.06.006
16. Cervical dysplasia in HIV infected women in Maiduguri. Chama CM, Nggada H, Gaushau W, Trop J Obstet Gynaecol 2005 25 3 286 288
17. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1.Women's Interagency HIV Study Group. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. J Acquir Immune Defic Syndr 1999 21 33 41 10.1097/00126334-199905010-00005 10235512
18. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, et al. J Natl Cancer Inst 2005 95 1062 1071
19. Assessment of risk factors and human papillomavirus (HPV) related pathogenic mechanisms of CIN in HIV positive and HIV negative women. Study design and baseline data of the HPV Pathogen ISS study. Branca M, Costa S, Mariani I, Sesti F, Agarossi A, di Carlo A, et al. Eur J Gynaecol Oncol 2004 25 689 698 15597844
20. Comparative prevalence, incidence and short term prognosis of cervical squamous intraepithelial lesions amongst HIV positive and HIV negative women. Six C, Heard I, Bergeron C, Orth G, Poveda JD, Zagury P, et al. AIDS 1998 12 1047 1056 10.1097/00002030-199809000-00013 9662202
21. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Grinsztejn B, Veloso VGC, Levi JE, Velasque L, Luz PM, Friedman RK, Andrade AC, Moreira RI, Russomano F, Pilotto JH, Bastos FLD, Palefsky J, Int J Infect Dis 2009 13 72 80 10.1016/j.ijid.2008.03.031 18632296
22. HPV vaccines and prevention of cervical cancer in Africa. Okonofua F, Afr J Reprod Health 2007 11 7 9
23. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJF, Meijer C, et al. Br J Cancer 2004 90 638 645 10.1038/sj.bjc.6601515 14760378
24. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M, Int J Cancer 2012 130 2111 2117 10.1002/ijc.26211 21630264
25. Genital human papillomavirus genotypes in Northwestern Tanzania. Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW, J Clin Microbiol 2003 41 9 4451 4453 10.1128/JCM.41.9.4451-4453.2003 12958291
26. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID- PATH431>3.0.CO;2-F 10451482
27. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, J Natl Cancer Inst 1995 87 796 802 10.1093/jnci/87.11.796 7791229
28. Human papillomavirus infection in women with and without cervical cancer in Ibadan. Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJF, Meijer CJLM, Clifford GM, Niger Infect Agents Cancer 2010 5 24 doi:10.1186/1750-9378-5-24 10.1186/1750-9378-5-24
29. Federal Ministry of Health, National policy on cervical cancer prevention and control Abuja Nigeria: Federal Ministry of Health in Nigeria 2011
30. National Agency for the control of AIDS (NACA), Antiretroviral therapy in Nigeria 2011 http://www.naca.gov.ng/content/view/417/language,en
31. Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women. Ezechi OC, Gab Okafor CV, Ostergren PO, Odberg Pettersson K, BMC Public Health 2013 13 46 doi:10.1186/1471-2458-13-46 10.1186/1471-2458-13-46 23327453
32. Prevalence of human Papillomavirus infection in women in Benin, West Africa. Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, et al. Virol J 2011 8 514 http://www.virologyj.com/content/8/1/514 10.1186/1743-422X-8- 514 22074103
33. The impacts of culture on the transmission of infection: the case of Awka South, Anambra state. Ebisi NT, Afr J Soc Sci 2012 2 4 173 190
34. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX, Lancet Infect Dis 2007 7 7 453 459 10.1016/S1473-3099(07)70158-5 17597569
35. Adolescent HIV-Cause for Concern in Southern Africa. Gray GE, PLoS Med 2010 7 2 1000227 doi:10.1371/journal.pmed.1000227 10.1371/journal.pmed.1000227 20161804
36. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, et al. AIDS 2009 23 2039 2046 10.1097/QAD. 0b013e32833016ce 19684508
37. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic. Ferrand RA, Banson T, Musvaire P, Larke N, Nathoo K, et al. PloS Med 2010 7 1000178 doi:10.1371/journal.pmed.1000178 10.1371/journal.pmed.1000178 20126383
38. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. J Natl Cancer Inst 1999 91 226 236 10.1093/jnci/91.3.226 10037100
39. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. De Vuyst H, Lilloc F, Broutetd N, Smithe JS, Eur J Cancer Prev 2008 17 545 554 10.1097/CEJ.0b013e3282f75ea1 18941376
40. Viral latency-the papillomavirus model. Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, Chow LT, et al. Dev Biol 2001 106 443 451
41. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Heard I, Palefsky JM, Kazatchkine MD, Antivir Ther 2004 9 13 22 15040532
42. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, et al. J Infect Dis 2001 184 547 551 10.1086/322856 11494160
43. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, et al. J Infect Dis 2003 188 128 136 10.1086/375783 12825181
44. Highly active antiretroviral therapy and cervical intraepithelial neoplasia. Moore AL, Sabin CA, Madge S, Mocroft A, Reid W, Johnson MA, AIDS 2002 16 927 929 10.1097/00002030-200204120-00014 11919496
45. National Population Commission, Nigeria, 2006 Population & Housing Census Report Abuja Nigeria 2007 http://www.population.gov.ng/
46. Kish L, Survey Sampling New York: John Wiley & Sons, Inc 1965 41